Long-term follow-up study 52 patients (%)

Patients lost at long-term follow-up 48 patients (%)

Age

49 years (max 76, min 19)

57 years (max 76, min 19)

Sex (M:F)

2.1 (35/17)

1.3 (27/21)

Histology (HGG/LGG)

3.7 (41/11)

3.6 (36/10)

Tumor location

Frontal

36 (69.2%)

24 (50.0%)

Temporal

19 (36.5%)

18 (38.5%)

Parietal

13 (25.0%)

14 (29.2%)

Occipital

5 (9.6%)

5 (10.4%)

Insula

6 (11.5%)

2 (4.2%)

Other

6 (11.5%)

6 (12.5%)

Multilobar

25 (48.1%)

12 (25.0%)

Seizure type

Motor

15 (28.8%)

16 (33.3%)

Somato-sensory

8 (15.4%)

3 (6.3%)

Loss of consciousness

10 (19.2%)

10 (20.8%)

Other

8 (15.4%)

4 (8.3%)

Tonic-Clonic

20 (38.5%)

25 (52.1%)

Frequency

Low (< 1/Month)

31 (59.6%)

37 (71.2%)

High (> 1/Month)

21 (40.4%)

11 (22.9%)

Weekly

8 (15.4%)

0

Daily

9 (17.3%)

1 (2.0%)

Status epilepticus

4 (7.7%)

8 (16.7%)

Surgery

Radical surgery

13 (25.0%)

25 (52.1%)

Post-surgery residue

33 (63.5%)

20 (41.6%)

General prognosis

Dead

23 (44.2%)

21 (43.8%)